Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy.

about

Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy.

Item

http://www.wikidata.org/entity/Q40148468

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Occurrence of late relapse of ...... feron-ribavirin-based therapy.

@en

type

Item

label

Occurrence of late relapse of ...... feron-ribavirin-based therapy.

@en

prefLabel

Occurrence of late relapse of ...... feron-ribavirin-based therapy.

@en

P1476

Occurrence of late relapse of ...... feron-ribavirin-based therapy.

@en

P2093

Hidemi Goto

http://www.w3.org/2001/XMLSchema#string

Masatoshi Ishigami

http://www.w3.org/2001/XMLSchema#string

Satoshi Yasuda

http://www.w3.org/2001/XMLSchema#string

Takashi Honda

http://www.w3.org/2001/XMLSchema#string

Teiji Kuzuya

http://www.w3.org/2001/XMLSchema#string

Tetsuya Ishikawa

http://www.w3.org/2001/XMLSchema#string

Yoji Ishizu

http://www.w3.org/2001/XMLSchema#string

Yoshiki Hirooka

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

Identification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 Protein

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b, 1c, and 2a

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study.

Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy.

P31

scholarly article

P356

10.1111/HEPR.12929

http://www.w3.org/2001/XMLSchema#string

P50

Kazuhiko Hayashi

P577

2017-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28643404

http://www.w3.org/2001/XMLSchema#string

P921

diagnostic test

virology